Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer

BACKGROUND: CA125 is a prevalently used serum biomarker for detecting ovarian cancer over the last three decades. However, it has a significant deficiency in screening for early-stage cancer. With the purpose of exploring an effective approach to improve its performance in early diagnosis, we invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zhuowei, He, Yifeng, Zhang, Yue, Chen, Mo, Song, Keqi, Huang, Yuting, Li, Qing, Di, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930842/
https://www.ncbi.nlm.nih.gov/pubmed/29716620
http://dx.doi.org/10.1186/s12967-018-1489-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930842/
https://www.ncbi.nlm.nih.gov/pubmed/29716620
http://dx.doi.org/10.1186/s12967-018-1489-4

Ejemplares similares